EFFECTIVENESS OF DOSAGE FORMS WITH FLURENIZIDE IN PREVENTIVE CARE AND TREATMENT OF DANGEROUS AND CONTROLLED INFECTIOUS DISEASES
Introduction. Creation of an effi cient and safe medication is based on the knowledge of the world’s best achievements in medicine and pharmacy. Development of new original medications and dosage forms, a study of their specifi c medicinal properties, application and advantages over well-known brands are important for achieving high-quality medical assistance.
The innovative product – Flurenizide substance – has served as the basis for new dosage forms (solid, semisolid, and liquid) intended for preventive care and treatment of dangerous and controlled infectious diseases in human and veterinary medicine.
Development and introduction of new effi cient antimicrobial, antiviral, and antiseptic medications into medical practice is a relevant task today. Variety of microorganisms, their ability to mutate, and create forms, which are resistant to existing chemotherapeutic medications urges us to seek new and more eff ective medications for the prevention and treatment of infectious diseases. In the early ‘90s, researchers at Lviv State Medical Institute received an organic compound patented under the name «Flurenizide TM. Pharmaceuticals and medicines used for people and animals». Flurenizide is registered in the State Register of medicines of Ukraine as a new original Ukrainian drug with antituberculous and antimicrobial eff ect (registration no. Р.10.00/02305 dated October 12.000).
Aim of study was information research of the scientifi c literature.
Materials and methods. A profound analysis of the scientifi c literature, patent information of Ukrainian and foreign scientists showed the promising nature of fl uorine application in medicine and pharmacy. Among them, there are eff ective substances that are suggested for preparing both fi nished pharmaceutical forms and those, which are already under production (Flo-renalum, Amixin, etc.). Research methods included microbiological, pharmacological clinical and pharmaceutical development studies.
Results: fl urenizide is an important biomolecule with properties, which are optimal for obtaining the entirety of pharmacological eff ects – antimicrobial (antituberculous, antichlamydial), immunemodulating, antioxidant, antiradical, hepatoprotective, anti-infl ammatory, etc. We have described new dosage forms (solid, soft, and liquid), which exhibit a higher clinical eff ect. They are intended for the prevention and treatment of hazardous and controlled infectious diseases in medicine and veterinary medicine.
Condusions: The application of Flurenizide in various dosage forms extends the range of drugs with antiviral, antimicrobial, and antiseptic eff ect to meet the needs of humane and veterinary medicine.
Petrukh L.I., Pavlenko A.V. Flurenizyd from synthesis to drug standards in the treatment of tuberculosis and chlamydia. Thematic bibliograph. pokazhch. (1990-2011); foreword by Petrukh LI. Lviv: Shevchenko Scientific Society; 2012. 420 p .
Certificate Ukraine to sign number of goods and services 24,424 «Flurenizyd». Pharmaceutical and medicines that are used to people and animal. Ukraine; Number 99020381; zayavl.10.02.99; publ. 15.04.02. Byul. №4.
Petrukh L.I. Fluorenes as tuberculostatics, Flurenizide: microbiological, pharmacological and clinical aspects. Lviv; 2008. 469 p.
Sybirna R.I., Sibirny A.V., Yukalo V.E. Research flurenizydu therapeutic activity in experimental tuberculosis. Pharmaceutical zhurnal. 2000; 2: 72-75.
Sibirny A.V. Frequency selection and sensitivity mycobacterioses pathogens and opportunistic infections of the respiratory and newly synthesized to known drugs [dissertation]. Kyiv, UA; 2003. 18 p.
Mykhalyk O.I. Development, research and standardization of solid dosage forms flurenizydu [dissertation]. Kharkiv, UA; State Scientific Center for Medicines; 2003. 19 p.
Petruh L.I., Kozhakina I.P., Borodina L.O., Danevych O.I., Heorhiyevskyy V.P. Mykhalyk O.I., Tkach O.A. Тablet antimicrobial action. Ukraine patent 36112 С2. 2003 Jan. 15.
Blikhar V.E., Maltsev V.I., Morozov A.M. and forth. State Form drugs MON Ukraine. Kyiv; 2012. 209 p.
Kozubskyy Y.O. Efficiency of chemotherapy of pulmonary tuberculosis in adolescents using isoniazid and Flurenizyde [dissertation]. Kyiv, UA; 1997. 24 p.
Kostik O. Tuberculosis in a teaching age children residing in contaminated territories by radionuklidamy [dissertation]. Kyiv, UA; Institute ftyziatriyi and pulmonolohiyi; 2000. 36 p.
Mykhalchuk B.I. Clinical and microbiological substantiation of Flurenizyde chemotherapy in patients with newly diagnosed destructive pulmonary tuberculosis [dissertation]. Kyiv, UA; 1997. 19 р.
The list of drugs approved for use in Ukraine, prescription from pharmacies and pharmacy items. FLURENIZYD. Flurenizide. Dosage form: vaginal suppositories of 0.1 g №10 (5x2) in blisters. Ukraine 494.6782. 2002 April 01.
Pronyuk A.V. Development and standardization of Flurenizyde suppositories. [dissertation]. Kharkiv, UA; State Scientific Center for Medicines; 2003. 17 p.
Registration certificate for vaginal suppositories of 0.1 Flurenizyde, №10, production of «Monfarm.» Number R.10.01. 03849. 2001. Octob.10.
Abrahamovych A.A., Zhurayev R.K. The first experience of Flurenizyde in treatment of patients with reactive arthritis chlamydial etiology. Ukrainian Journal of Rheumatology. 2004; 4 (18): 14-16.
Boychuk A.V. Diagnosis and treatment of inflammation of the uterus and its appendages, depending on the immune, hormone and antioxidant systems of the body [dissertation]. Kyiv, UA; 2001. 40 p.
Hevko A.V. Clinical and pathogenetic substantiation of Flurenizyde immunomodulatory and as a means antyhlamidiynoho in patients with chronic pyelonephritis [dissertation]. Ivano-Frankivsk, UA; Ivano-Frankivsk State Medical Academy. 2003.19 p.
Buyanov O.V., Boychuk A.V., Kulinich T.I., Petrukh L.I., Pronyuk O.V. Flurenizyd in treatment of urogenital chlamydia in women. Dosage flurenizydu as vaginal suppositories in treatment combined chlamydial infections in gynecology. Medical City. оbstetrics and gynecology: іnform. bulletin. 2005; 2: 39 p.
Petrukh L.I., Pavlenko A.V. Chlamydia. Flurenizyd. Suppositories antyhlamidiynoyi action; foreword by Petrukh LI. Lviv; 2015. 340 p .
Zhurayev R.K. Clinical and immunological study Flurenizyde use in treatment of patients with reactive arthritis, combined with chronic urogenital chlamydiosis [dissertation]. Kyiv, UA; 2007. 20 p.
Petrukh L.I., Yurevich V.R., Novitsky I.J., Yurevich D.G., Mykhalyk O.I. Еye ointment to treat burns and bacterial inflammation of the cornea. Ukraine patent 20624 A. 1997 May 08.
Turkevych O. Treatment of dermatitis and eczema Workers in chemical industry based on skin and physiological state of some indicators of homeostasis [dissertation]. Kyiv, UA; National Medical University; 2007. 20 p.
Kunovskyy V. The use of a new drug flumexide in the complex surgical treatment of purulent-inflammatory diseases of the skin and subcutaneous base [dissertation]. Lviv, UA; Lviv National Medical University; 1998. 20 p.
Petrukh L.I., Kunovskyy V.V., Andryushchenko V.P. Tools for treatment of purulent inflammation of the skin and subcutaneous tissue. Ukraine patent 195504 A. 1997 Decem. 25.
Hutor N.S. Optimization diagnosis, prevention and treatment alveolitiv (experimentally-clinical research) [dissertation]. Odessa, UA; State Institution «Institute stomatolohiyi AMI divide in Ukrain»; 2011. 20 p.
Petrukh L.I., Saldan Y.R., Gerashchenko I.I., Saldan V.I., Mykhalyk O.I. Аntiseptic. Ukraine patent 75600. 2006 May 15.
Petrukh L.I., Ostrovska L.L., Mykhalyk O.I., Ostrovskyy Ya.Z. Use of a pharmaceutical composition for the treatment of chronic otodectosis. Ukraine patent 82787. 2008 May 12.
Abstract views: 109 PDF Downloads: 48